AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34130339 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily dosing regimen or evening intake of aspirin
Number of subjects: 0
Study 34130339 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric-coated formulations of aspirin
Number of subjects: 0
Study 34130339 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter aspirin duration strategies after percutaneous coronary interventions
Number of subjects: 0
Study 34130339 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin for reducing the risk of colorectal cancer and other types of cancer
Number of subjects: 0
Study 32161164 — intervention group
Group type: EXPERIMENTAL
Intervention: MAP 100‐110 mm Hg
Number of subjects: 8
Study 32161164 — intervention group
Group type: COMPARATOR
Intervention: MAP 60‐80 mm Hg
Number of subjects: 8
Study 32161164 — intervention group
Group type: EXPERIMENTAL
Intervention: EtCO2 38‐40 mm Hg
Number of subjects: 8
Study 32161164 — intervention group
Group type: COMPARATOR
Intervention: EtCO2 24‐26 mm Hg
Number of subjects: 8
Study 35361735 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Isometric Bench Press (SIBP)
Number of subjects: 16
Study 35361735 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Isometric Bench Press (MIBP)
Number of subjects: 16
Study 33989641 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ibuprofen
Number of subjects: 75
Study 33989641 — intervention group
Group type: EXPERIMENTAL
Intervention: IV paracetamol
Number of subjects: 75
Study 33989641 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 75
Study 33006195 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity (HI) TENS
Number of subjects: 10
Study 33006195 — intervention group
Group type: COMPARATOR
Intervention: Sub-sensory Low-Intensity (LI) TENS
Number of subjects: 10
Study 33779383 — intervention group
Group type: EXPERIMENTAL
Intervention: High doses of THC
Number of subjects: 0
Study 33779383 — intervention group
Group type: COMPARATOR
Intervention: Randomized clinical trials of psilocybin
Number of subjects: 0
Study 33271847 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to desktop/laptops
Number of subjects: 2039
Study 33271847 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of mobile internet
Number of subjects: 2039
Study 33271847 — intervention group
Group type: EXPERIMENTAL
Intervention: Experience of social media
Number of subjects: 2039
Study 33271847 — intervention group
Group type: EXPERIMENTAL
Intervention: Link between social media experience and negative outcomes
Number of subjects: 2039
Study 33271847 — intervention group
Group type: EXPERIMENTAL
Intervention: Access improvements
Number of subjects: 2039
Study 33271847 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive measures for harmful media usage
Number of subjects: 2039
Study 35038699 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous blood pressure monitoring (Finapres) for 5 min in supine position and 3 min standing or sitting when unable to stand.
Number of subjects: 37
Study 35038699 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions to warm hands and adjusting cuff pressure sizes were attempted if no signal was obtained.
Number of subjects: 37
Study 35038699 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 37
Study 32601670 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Brains program (walking using time goals)
Number of subjects: 23
Study 32601670 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Brains-Fitbit program (walking reinforced by a Fitbit)
Number of subjects: 23
Study 32601670 — intervention group
Group type: COMPARATOR
Intervention: Educational control (not detailed in the abstract)
Number of subjects: 23
Study 32516959 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaine supplementation (BET; N = 14)
Number of subjects: 29
Study 32516959 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (PLA; N = 15)
Number of subjects: 29
Study 32516959 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaine supplementation (BET)
Number of subjects: 29
Study 36417058 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec
Number of subjects: 561
Study 33511817 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (3 sessions per week, 30 to 45 minutes each session, 50-70% maximum heart rate)
Number of subjects: 30
Study 33511817 — intervention group
Group type: COMPARATOR
Intervention: Control group (no aerobic exercise)
Number of subjects: 30
Study 32485433 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) to the subgenual anterior cingulate cortex (sgACC) or nucleus accumbens (NAc)
Number of subjects: 7
Study 32485433 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS)
Number of subjects: 7
Study 35478399 — intervention group
Group type: EXPERIMENTAL
Intervention: Drugs with orphan drug designation
Number of subjects: 130
Study 34886880 — intervention group
Group type: EXPERIMENTAL
Intervention: ragweed SLIT-tablet (12 Amb a 1-U)
Number of subjects: 246
Study 34886880 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 246
Study 36273186 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity-modulated proton therapy (IMPT)
Number of subjects: 232
Study 36273186 — intervention group
Group type: COMPARATOR
Intervention: Intensity-modulated radiation therapy (IMRT)
Number of subjects: 232
Study 33853878 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinued oxytocin stimulation
Number of subjects: 1200
Study 33853878 — intervention group
Group type: COMPARATOR
Intervention: Continued oxytocin stimulation
Number of subjects: 1200
Study 33853878 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinued oxytocin stimulation in parous women with no previous caesarean section
Number of subjects: 1200
Study 33853878 — intervention group
Group type: COMPARATOR
Intervention: Continued oxytocin stimulation in parous women with no previous caesarean section
Number of subjects: 1200
Study 34533477 — intervention group
Group type: EXPERIMENTAL
Intervention: K-wire fixation and above-elbow cast
Number of subjects: 128
Study 34533477 — intervention group
Group type: COMPARATOR
Intervention: Above-elbow cast
Number of subjects: 128
Study 34533477 — intervention group
Group type: EXPERIMENTAL
Intervention: Malunion group (casting)
Number of subjects: 128
Study 34533477 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptable alignment group (no malunion)
Number of subjects: 128
Study 34533477 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with limited forearm rotation
Number of subjects: 128
Study 32032428 — intervention group
Group type: EXPERIMENTAL
Intervention: 110 µm cap thickness
Number of subjects: 100
Study 32032428 — intervention group
Group type: COMPARATOR
Intervention: 140 µm cap thickness
Number of subjects: 100
Study 35307068 — intervention group
Group type: EXPERIMENTAL
Intervention: Dachengqi decoction combined with octreotide
Number of subjects: 64
Study 35307068 — intervention group
Group type: COMPARATOR
Intervention: Conventional western medicine (octreotide + symptomatic treatment)
Number of subjects: 64
Study 32115639 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-marker technique (TiO2)
Number of subjects: 8
Study 32115639 — intervention group
Group type: EXPERIMENTAL
Intervention: Double n-alkane ratio technique (ALK)
Number of subjects: 8
Study 32115639 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse dose technique (Yttrium)
Number of subjects: 8
Study 32115639 — intervention group
Group type: COMPARATOR
Intervention: Fresh-cut perennial ryegrass (Lolium perenne L.)
Number of subjects: 8
Study 32115639 — intervention group
Group type: COMPARATOR
Intervention: Fresh-cut plantain (Plantago lanceolata)
Number of subjects: 8
Study 33477158 — intervention group
Group type: EXPERIMENTAL
Intervention: Argatroban injection 60 mg intravenously for 2 days, then 10 mg bid for 5 days (total 7 days)
Number of subjects: 344
Study 33477158 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (control group)
Number of subjects: 344
Study 32981799 — intervention group
Group type: EXPERIMENTAL
Intervention: One-anastomosis gastric bypass (OAGB)
Number of subjects: 50
Study 32425024 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic technique for implant site preparation
Number of subjects: 49
Study 32425024 — intervention group
Group type: COMPARATOR
Intervention: Conventional drilling technique
Number of subjects: 49
Study 32425024 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Ultrasonic and Conventional)
Number of subjects: 49
Study 34986027 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergaming session (EGS) in the ExerCube (25 minutes)
Number of subjects: 28
Study 34986027 — intervention group
Group type: COMPARATOR
Intervention: Moderate-intensity endurance exercise (MIEE) session on a treadmill (35 minutes, 65%-70% of maximal heart rate)
Number of subjects: 28
Study 33334633 — intervention group
Group type: EXPERIMENTAL
Intervention: Online training module for shared decision making
Number of subjects: 187
Study 33334633 — intervention group
Group type: COMPARATOR
Intervention: Waiting control group
Number of subjects: 187
Study 32430457 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic software 'prompt' with health care professional training
Number of subjects: 2721
Study 32430457 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 2721
Study 36322033 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascia iliaca block with general anaesthesia (GA)
Number of subjects: 28
Study 36322033 — intervention group
Group type: COMPARATOR
Intervention: Subarachnoid anaesthesia with morphine and bupivacaine (SAB)
Number of subjects: 28
Study 34432383 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study 33544911 — intervention group
Group type: EXPERIMENTAL
Intervention: High-quality reports
Number of subjects: 50
Study 33544911 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-quality reports
Number of subjects: 50
Study 33544911 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-quality reports
Number of subjects: 50
Study 33544911 — intervention group
Group type: COMPARATOR
Intervention: Reports from Europe
Number of subjects: 50
Study 33544911 — intervention group
Group type: COMPARATOR
Intervention: Reports published in impact factor journals
Number of subjects: 50
Study 33544911 — intervention group
Group type: COMPARATOR
Intervention: Reports adhering to CONSORT guidelines
Number of subjects: 50
Study 33544911 — intervention group
Group type: COMPARATOR
Intervention: Clinical trials with protocols registered a priori
Number of subjects: 50
Study 32446832 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapinarof cream 0.5% QD
Number of subjects: 0
Study 32446832 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapinarof cream 1% QD
Number of subjects: 0
Study 32446832 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapinarof cream 0.5% BID
Number of subjects: 0
Study 32446832 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapinarof cream 1% BID
Number of subjects: 0
Study 32446832 — intervention group
Group type: COMPARATOR
Intervention: Vehicle QD
Number of subjects: 0
Study 32446832 — intervention group
Group type: COMPARATOR
Intervention: Vehicle BID
Number of subjects: 0
Study 35359909 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative neuromuscular training (6 months of supervised physical exercise and home-based exercise)
Number of subjects: 127
Study 35359909 — intervention group
Group type: COMPARATOR
Intervention: Usual care + unsupervised written home-based training program (active control)
Number of subjects: 127
Study 33683083 — intervention group
Group type: EXPERIMENTAL
Intervention: Halobetasol Propionate 0.01% lotion
Number of subjects: 119
Study 33683083 — intervention group
Group type: COMPARATOR
Intervention: Vehicle lotion
Number of subjects: 119
Study 32482645 — intervention group
Group type: EXPERIMENTAL
Intervention: csDMARD tapering first
Number of subjects: 189
Study 32482645 — intervention group
Group type: COMPARATOR
Intervention: TNF-inhibitor tapering first
Number of subjects: 189
Study 32482645 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 189
Study 35915460 — intervention group
Group type: EXPERIMENTAL
Intervention: PhunkyFoods programme (n = 210)
Number of subjects: 420
Study 35915460 — intervention group
Group type: COMPARATOR
Intervention: Usual school curriculum (n = 210)
Number of subjects: 420
Study 33642167 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 972
Study 33642167 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers in patients with LVEF ≤40%
Number of subjects: 972
Study 33642167 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers in patients with LVEF >40%
Number of subjects: 972
Study 32933119 — intervention group
Group type: EXPERIMENTAL
Intervention: Person-centered nursing intervention program for frailty (PNIF)
Number of subjects: 40
Study 32933119 — intervention group
Group type: COMPARATOR
Intervention: Control group (lectures about frailty prevention)
Number of subjects: 40
Study 35257622 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (200mg)
Number of subjects: 0
Study 35257622 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32089099 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebellar stroke group
Number of subjects: 33
Study 32089099 — intervention group
Group type: COMPARATOR
Intervention: Hemispheric stroke group
Number of subjects: 33
Study 35833413 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy + surgery (RT+S)
Number of subjects: 321
Study 35833413 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (S)
Number of subjects: 321
Study 35833413 — intervention group
Group type: COMPARATOR
Intervention: Preoperative radiotherapy (RT)
Number of subjects: 321
Study 34518098 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS over M1
Number of subjects: 80
Study 34518098 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS over S1
Number of subjects: 80
Study 34518098 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS over DLPFC
Number of subjects: 80
Study 34518098 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 80
Study 34799418 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus lenvatinib
Number of subjects: 875
Study 34799418 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel plus carboplatin
Number of subjects: 875
Study 33743385 — intervention group
Group type: EXPERIMENTAL
Intervention: MHP+TAU
Number of subjects: 124
Study 33743385 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 124
Study 34425247 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory-reframing intervention
Number of subjects: 65
Study 34425247 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 65
Study 33606965 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression garment stockings (CGS)
Number of subjects: 20
Study 33606965 — intervention group
Group type: COMPARATOR
Intervention: No compression garment stockings (control)
Number of subjects: 20
Study 32166534 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (dDAVP) administered intravenously in doses from 0.25 to 2.0 µg/kg over two consecutive days.
Number of subjects: 32
Study 32166534 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (dDAVP) treatment.
Number of subjects: 32
Study 34420970 — intervention group
Group type: EXPERIMENTAL
Intervention: BetterBrains intervention (online person-centered risk factor management program)
Number of subjects: 1510
Study 34420970 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducational health information (provided to both groups)
Number of subjects: 1510
Study 32394228 — intervention group
Group type: EXPERIMENTAL
Intervention: Lixisenatide (20 μg single-dose injection)
Number of subjects: 24
Study 36351926 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g of CaCO3
Number of subjects: 2
Study 36351926 — intervention group
Group type: COMPARATOR
Intervention: 0 g of CaCO3
Number of subjects: 2
Study 36351926 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g of CaCO3
Number of subjects: 2
Study 36351926 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g of CaCO3
Number of subjects: 2
Study 36351926 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g of CaCO3
Number of subjects: 2
Study 36351926 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype I
Number of subjects: 2
Study 36351926 — intervention group
Group type: COMPARATOR
Intervention: Genotype II
Number of subjects: 2
Study 36351926 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype I and 5 g of CaCO3
Number of subjects: 2
Study 36351926 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with stalk height
Number of subjects: 2
Study 36351926 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with stalk diameter
Number of subjects: 2
Study 36351926 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with number of mushroom branches
Number of subjects: 2
Study 36351926 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with number of productive bags
Number of subjects: 2
Study 36351926 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with number of fruits
Number of subjects: 2
Study 36351926 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with fruit weight
Number of subjects: 2
Study 36351926 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with dry weight
Number of subjects: 2
Study 33271534 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma magnesium concentrations in quartile 1 (<0.76 mmol/L)
Number of subjects: 456
Study 33271534 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma magnesium concentrations in quartile 4 (≥0.89 mmol/L)
Number of subjects: 456
Study 33271534 — intervention group
Group type: COMPARATOR
Intervention: Plasma magnesium concentrations in quartile 3 (0.83 to <0.89 mmol/L)
Number of subjects: 456
Study 36226464 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab
Number of subjects: 2338
Study 36226464 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2338
Study 36226464 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab (responders)
Number of subjects: 2338
Study 36226464 — intervention group
Group type: COMPARATOR
Intervention: Placebo (responders)
Number of subjects: 2338
Study 33961212 — intervention group
Group type: EXPERIMENTAL
Intervention: Contextual cohort
Number of subjects: 0
Study 33961212 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 35212645 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga and meditation for 60 minutes two times a week for 10 weeks, including during labor.
Number of subjects: 90
Study 35212645 — intervention group
Group type: COMPARATOR
Intervention: Routine midwifery care during labor (Control group).
Number of subjects: 90
Study 32833845 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonprogressive KCN group (serum vitamin D levels: 12.77 ± 5.52 ng/mL)
Number of subjects: 55
Study 32833845 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive KCN group (serum vitamin D levels: 11.78 ± 4.32 ng/mL)
Number of subjects: 55
Study 32833845 — intervention group
Group type: COMPARATOR
Intervention: Control group (serum vitamin D levels: 17.40 ± 5.12 ng/mL)
Number of subjects: 55
Study 32833845 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (serum vitamin B12, FA, and Ca levels)
Number of subjects: 55
Study 36214945 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy for insomnia (exact dosage and duration not specified)
Number of subjects: 187
Study 36214945 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group not specified)
Number of subjects: 187
Study 34389017 — intervention group
Group type: EXPERIMENTAL
Intervention: Step-Dep (stepped care program)
Number of subjects: 236
Study 34389017 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 236
Study 35100035 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrus depressa Hayata fruit extract (CFEx)
Number of subjects: 40
Study 35100035 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 32089107 — intervention group
Group type: EXPERIMENTAL
Intervention: Intended but failed to apologize
Number of subjects: 284
Study 32089107 — intervention group
Group type: COMPARATOR
Intervention: Refused to apologize or whose apologies were rejected
Number of subjects: 284
Study 33143931 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed hemodynamic therapy
Number of subjects: 401
Study 33143931 — intervention group
Group type: COMPARATOR
Intervention: Restrictive normovolemic therapy
Number of subjects: 401
Study 32312645 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented femoral and tibial implants
Number of subjects: 130
Study 32312645 — intervention group
Group type: COMPARATOR
Intervention: Cemented tibial implant, uncemented femoral implant (hybrid group)
Number of subjects: 130
Study 34494090 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 139242
Study 34494090 — intervention group
Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 139242
Study 34159934 — intervention group
Group type: EXPERIMENTAL
Intervention: EPEA using Bio-Well 2.0
Number of subjects: 114
Study 35894983 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycle ergometer intervention during 3 lessons per week at self-selected intensity
Number of subjects: 44
Study 35894983 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 44
Study 34763594 — intervention group
Group type: EXPERIMENTAL
Intervention: SonoVue and oxytocin (group A)
Number of subjects: 330
Study 34763594 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin (group B)
Number of subjects: 330
Study 34763594 — intervention group
Group type: EXPERIMENTAL
Intervention: SonoVue (group C)
Number of subjects: 330
Study 34763594 — intervention group
Group type: COMPARATOR
Intervention: Control (group D)
Number of subjects: 330
Study 36052473 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-components phytotherapic composed of Herniaria hirsuta and Peumus boldus plus water oral intake for 12 days/month over 3 months (Group A)
Number of subjects: 34
Study 36052473 — intervention group
Group type: COMPARATOR
Intervention: No adjuvant phytotherapy (Group B)
Number of subjects: 34
Study 33851854 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived financial barriers to screening
Number of subjects: 702